Dr. David Bearss is a trained cellular biologist and serial entrepreneur committed to finding cures for cancer. He is the CEO and co-founder of Biolexis Therapeutics (biolexistx.com) as well as six other biotech companies. In this episode, David discusses the advances in technology that expedite the drug discovery process. Biolexis’ Moleculern process utilizes artificial intelligence combined with a proprietary empirical compound library, discovering new drugs faster and cheaper than ever before. Having lost family and friends to cancer, he dedicated his career to combating this deplorable disease. As a result, the discoveries by David and his team have led to many lives saved. Thanks for your commitment, David!